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during the observation period were additional predictors. 
 Conclusions: Improvement in GFR over time predicted bet-
ter SRH at each period after KT. Decreased transplantation-
associated psychological distress and fewer late acute rejec-
tion episodes seemed to predict better SRH at a later fol-
low-up period. Despite these observations, higher SRH was 
associated with better clinical outcomes. 
 Copyright © 2011 S. Karger AG, Basel 
 Introduction 
 Self-rated health (SRH) is considered a reliable indica-
tor of mortality and morbidity in patients with end-stage 
renal disease (ESRD)  [1, 2] . Thong et al. [3] investigated 
the predictive utility of SRH, measured shortly after the 
start of dialysis, on mortality and found SRH to be an in-
dependent predictor of mortality in dialysis patients at up 
to 7 years of follow-up. Spiegel et al.  [4] indicated in their 
systematic review of ESRD the importance of SRH as it is 
connected with traditional biomarkers. Avitzur et al. [5] 
explored SRH in pediatric patients who were 10-year sur-
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 Abstract 
 Background: This prospective study explores and compares 
the relationship between patients’ self-rated health (SRH) af-
ter kidney transplantation (KT) at different follow-up periods 
and its medical and nonmedical predictors over time.  Meth-
ods: Patients (n = 128) who completed a questionnaire (the 
SRH question of the SF-36 and the End-Stage Renal Disease 
Symptom Checklist – Transplantation Module) were en-
rolled. Clinical data were retrieved from medical files. The 
sample was stratified into early (n = 89) and late (n = 39) co-
horts according to time since KT at baseline. Linear regres-
sion was used to identify predictors of SRH at follow-up.  Re-
sults: In both cohorts, a change in glomerular filtration rate 
(GFR) over time remained a predictor of SRH; in the early co-
hort, age was an additional predictor; in the late cohort, a 
change in transplantation-associated psychological distress 
over time and the number of late acute rejection episodes 
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vivors of transplantation and who had an excellent graft 
function and a high self-reported quality of life. Thus, 
SRH seems to be a predictor of future health status and 
has become an important outcome criterion in the evalu-
ation of medical treatment of ESRD  [6] .
 In previous studies of patients after kidney transplan-
tation (KT), improvements in SRH have been found to be 
associated with younger age, male gender, higher educa-
tion, higher socioeconomic status, higher social support 
and lower number of comorbidities – not only with the 
success of the transplantation  [7] . Studies in ESRD have 
focused mainly on associations between components of 
better self-perceived health and objective factors of high-
er graft function  [8, 9] . The subjective evaluation of the 
side effects of immunosuppressants  [10] as well as rejec-
tion episodes continues to be a significant problem in 
long-term attrition of graft function  [11] , and also seems 
to be connected to poorer SRH  [10] .
 To our knowledge, there is only one study analyzing 
the associations between a change in objective factors 
over time and SRH at follow-up  [12] . In addition, studies 
comparing predictors in SRH in prospective studies 
stratified by time after KT are lacking. Thus, the aim of 
this study was (a) to explore changes over time in the 
medical and nonmedical factors associated with SRH, 
and (b) to compare their associations with SRH accord-
ing to time since transplantation.
 Materials and Methods 
 Sample and Procedures 
 A total of 187 kidney transplant recipients in their 3rd (n = 134) 
and 12th (n = 53) month after successful transplant surgery at the 
Transplant Centre of Kosice from the Eastern Region of Slovakia 
were invited to participate at baseline examination. The sample 
was stratified according to time since KT at baseline and 2 cohorts 
of patients were formed: early patients (3 months after KT at base-
line) and late patients (12 months after KT at baseline). The fol-
low-up examination took place in the 12th month after KT for the 
early cohort and in the 24th month after KT for the late cohort. 
All patients with a functional transplanted kidney (n = 142) who 
agreed to participate were included. The baseline examination for 
our sample was performed in the 3rd and 12th month after a suc-
cessful KT. We did this because the first 3 months after KT are 
usually considered as the most problematic period which is asso-
ciated with dramatic changes, increased morbidity and even mor-
tality  [13] . Additionally, an improvement in self-perceived health 
most often occurs during the first 2 years after KT  [14] . The exclu-
sion criteria were the presence of mental retardation, organic psy-
cho-syndrome, severe dementia or other psychiatric diseases 
mentioned in the medical record. Altogether, 3 patients (1.6%) 
were excluded at the baseline examination, 7 (3.7%) refused to 
participate, 33 (17.6%) provided incomplete questionnaires and 2 
(1.1%) died after baseline; thus, 142 patients (75.9%) were included 
in the analysis. At follow-up, 14 patients (9.9%) provided incom-
plete questionnaires, resulting in 128 patients with a functional 
transplanted kidney (a response rate of 90.1%) at the follow-up 
examination.  Figure 1 presents more detailed information about 
the participants.
 Data collection took place from 2003 to 2010 in Kosice. Pa-
tients provided information about sociodemographic variables 
and filled in the questionnaires. All participants were interviewed 
during regular outpatient clinical visits by trained personnel in-
dependent of the transplant team. Medical data were retrieved 
from medical records.
 Only patients who signed informed consent prior to the study 
were included. The local ethics committee of Kosice approved the 
study.
 Measures 
 Sociodemographic data included age and gender.  SRH was 
measured using the first question of the Short-Form Health Sur-
vey (SF-36)  [15] . The SF-36 questionnaire consists of eight sub-
scales: physical functioning, physical role limitations, bodily 
pain, vitality, general health perception, social functioning, emo-
tional role limitations and mental health  [15, 16] . All of the eight 
subscales are coded and transformed into a scale from 0 (poor 
health) to 100 (excellent health) in which they are presented as 
standard SF-36 scores between 0 and 100, with higher scores in-
dicating better health status  [15] . SRH can also be determined in 
this way from a single item in the SF-36. The validity and reliabil-
ity of the SF-36 and its first item have been confirmed in patients 
with renal disease, including those after KT  [8, 16–18] .
 Side effects of immunosuppressive treatment were assessed by 
the End-Stage Renal Disease Symptom Checklist – Transplanta-
tion Module (ESRD SCL-TM), which consists of six subscales: 
limited physical capacity (10 items), limited cognitive capacity (8 
items), cardiac and renal dysfunction (7 items), side effects of cor-
ticosteroids (5 items), increased growth of gum and hair (5 items) 
and transplantation-associated psychological distress (8 items) 
 [19] . This questionnaire can be used to measure the side effects of 
immunosuppressive treatment as well as its disease-specific dis-
tress  [19] . For each item, the patient can rate the severity of the 
symptom on a subscale from 0 (not at all) to 5 (extremely). The 
scores for the subscales are transformed into a scale score by di-
viding the severity index score by the number of items in the sub-
scales  [19] . Higher scores indicate a higher level of side effects 
from immunosuppressive treatment. In this sample, Cronbach’s 
  was 0.89 for limited physical capacity, 0.87 for limited cognitive 
capacity, 0.85 for cardiac and renal dysfunction, 0.81 for side ef-
fects of corticosteroids, 0.85 for increased growth of gum and hair 
and 0.84 for transplantation-associated psychological distress.
 Clinical data were retrieved from medical files. These includ-
ed serum creatinine, weight, duration of dialysis (in years), cur-
rent immunosuppressive treatment, function immediately after 
KT, number of early acute rejection episodes, number of late acute 
rejection episodes and chronic renal allograft dysfunction during 
the observation period. Glomerular filtration rate (GFR) was cal-
culated using the Cockcroft-Gault formula  [20] . Rejection epi-
sodes (early acute, late acute and chronic renal allograft dysfunc-
tion) were diagnosed after biopsy according to the Banff 2009 
update on diagnostic categories for renal allograft biopsies  [21] . 
An early acute rejection episode was defined as an acute rejection 
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episode occurring within 3 months, and a late acute rejection ep-
isode was defined as the last acute rejection episode occurring 
after 3 months independently of a previous early acute rejection 
episode  [22, 23] .
 Statistics 
 The Mann-Whitney U test and   2 test were used to check the 
differences between respondents and nonrespondents. Frequen-
cies, means and standard deviations were calculated for the sam-
ple description. Bivariate analyses were used for determining the 
strength and direction of the association between SRH at baseline 
and follow-up in both cohorts stratified by time after transplanta-
tion and the others factors. Stepwise linear regression was per-
formed in order to identify the predictors of SRH at follow-up in 
the cohorts stratified by time after transplantation (early cohort 
means 3 months and late cohort means 12 months from baseline). 
The independent variables were age, gender, change in all six sub-
scales of the ESRD SCL-TM questionnaire over time (between 
baseline and follow-up examination) and SRH at baseline from 
the SF-36 questionnaire, the change in GFR over time (between 
baseline and follow-up examination), duration of dialysis (in 
years), the number of early acute rejection episodes, the number 
of late acute rejection episodes, and chronic renal allograft dys-
function during the observation period. The Statistical Package 
for the Social Sciences (SPSS Inc., Chicago, Ill., USA) version 16.0 
was used for statistical analyses.
 Results 
 No significant differences were found between re-
spondents and nonrespondents regarding age, gender 
and medical factors, or between patients who provided 
complete and incomplete data. In addition, no significant 
differences regarding the independent variables were 
found between the cohorts stratified by time after trans-
plantation at baseline and at follow-up.
 In both cohorts, the side effects of immunosuppres-
sive treatment and the mean limited physical capacity 
significantly increased over time (between baseline and 
follow-up; p  ^  0.01); on the other hand, the mean trans-
plantation-associated psychological distress significantly 
decreased over time (p  ^  0.05). The mean SRH signifi-
cantly increased over time (p  ^  0.001) as did the mean 
GFR over time (p  ^  0.001). Other variables did not sig-
nificantly differ from baseline to follow-up. The pairwise 
associations for SRH at baseline and follow-up in the co-
horts with each of the factors are indicated in  table 1 . 
 Gender, the change in five subscales of the ESRD SCL-
TM over time (limited physical capacity, limited cogni-
 
Patients invited at 3rd month after KT (n = 134) Patients invited at 12th month after KT (n = 53) 
Early cohort Late cohort
Baseline examination 
(n = 142, RR = 75.9%) 
Follow-up examination 
(n = 128, RR = 90.5%) 
Patients responded at baseline at 3rd month
after KT (n = 100, RR = 74.6%) 
Patients responded at follow-up at 24th month
after KT (n = 39, RR = 92.9%) 
Patients excluded by exclusion criteria
Patients responded at follow-up at 12th month
after KT (n = 89, RR = 89.0%) 
Patients responded at baseline at 12th month
after KT (n = 42, RR = 79.2%) 
Patients refused to participate
Patients died before approaching 
Patients provided incomplete questionnaires
n = 3
n = 2
n = 3 n = 4
n = 28 n = 5











 Fig. 1. Flowchart diagram of the participants. RR = Response rate. 
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tive capacity, cardiac and renal dysfunction, the side ef-
fects of corticosteroids, and increased growth of gum
and hair), duration of dialysis, the number of early acute 
rejection episodes during the observation period, and 
chronic renal allograft dysfunction during the observa-
tion period were not predictors associated with SRH at 
follow-up in the regression models of the stratified co-
horts. 
 The regression model of the early cohort (n = 89) ex-
plained 66.2% of SRH variance at follow-up. A change in 
GFR over time contributed significantly to this model, as 
did age and SRH at baseline.
 The regression model of the late cohort (n = 39) ex-
plained 60.4% of SRH variance at follow-up. A change in 
GFR over time contributed significantly to this model, as 
did a change in transplantation-associated psychological 
distress over time, the number of late acute rejection epi-
sodes during the observation period, and SRH at base-
line. More detailed information is presented in  table 2 .
 Discussion 
 In this study we (a) explored changes over time in 
medical and nonmedical factors associated with SRH, 
and (b) compared their associations with SRH at follow-
up for early and late cohorts stratified by time since trans-
plantation. Over a follow-up observation period in the 





Time after KT during reviewing 3 months 100 (70.5) 0
12 months 42 (29.5) 89 (69.5)
24 months 0 39 (29.5)
Age (mean 8 SD) 48.7812.7* 49.7812.7*
Gender male 79 (55.6) 70 (54.7)
female 63 (44.4)*, # 58 (45.3)
ESRD SCL-TM limited physical capacity 1.51 (0.97)* 1.77 (0.97)*, #
limited cognitive capacity 1.22 (0.82)* 1.31 (0.86)*
side effects of corticosteroids 1.09 (0.92) 1.08 (0.78)
cardiac and renal dysfunction 1.04 (0.81)* 1.07 (0.84)*
increased gum and hair growth 0.76 (0.92) 0.78 (0.86)
transplantation-associated psychological distress 1.28 (0.85)* 1.17 (0.81)*, #
SRH (mean 8 SD) 47.82824.55 57.66824.43
GFR, ml/s (mean 8 SD) 0.9980.28 1.1280.37*, #
Function immediately after KT immediate function 74 (52.1) 66 (51.6)
delayed function 68 (47.9) 62 (48.4)
Immunosuppression treatment
at the time of interview
CsA+MMF+P 84 (59.2) 80 (62.5)
Tac+MMF+P 40 (28.2) 39 (30.5)
Tac+MMF 3 (2.1) 1 (0.8)
CsA+MMF 10 (7.0) 8 (6.2)
SIR+MMF+P/SIR+MMF 5 (3.5) 0
Duration on dialysis, years 3.65 (2.44) 3.51 (2.32)
Number of early acute rejection episodes during observation period 0.32 (0.55)* 0.31 (0.53)*
Number of late acute rejection episodes during observation period 0.15 (0.36)# 0.15 (0.35)#
Chronic renal allograft dysfunction during observation period 0.14 (0.35) 0.13 (0.32)#
V alues in parentheses represent percentages. Significant differences between baseline and follow-up are in bold font. 
Determining the strength of the association between SRH and each variable: * SRH in the early cohort; # SRH in the late cohort.
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early and late cohorts, SRH and GFR increased, while 
transplantation-associated psychological distress de-
creased. Previous studies have found an association be-
tween a higher GFR rate and better SRH  [8, 9] .
 In the early cohort, worse SRH at baseline as well as
at follow-up was associated with elderly, higher limited 
physical capacity, higher limited cognitive capacity, high-
er cardiac and renal dysfunction, higher transplantation-
associated psychological distress and early acute rejection 
episodes. Additionally, worse SRH at baseline was asso-
ciated with female gender and, at follow-up, with lower 
GFR. In the late cohort, worse SRH at baseline, as well as 
at follow-up, was associated with late acute rejection epi-
sodes. Moreover, worse SRH at baseline was associated 
with female gender and, at follow-up, lower GFR, higher 
limited physical capacity, higher transplantation-associ-
ated psychological distress and chronic renal allograft 
dysfunction. Associations between elderly, females, indi-
vidual evaluations in disease-specific distress, rejection 
episodes and poorer well-being were also found  [7–9, 18] .
 A change in GFR over time consistently predicted 
SRH at follow-up in both cohorts. Furthermore, better 
SRH at follow-up was predicted by fewer late acute rejec-
tion episodes during the observation period in the late 
cohort after KT. Age was a predictor of SRH at follow-up 
in the early cohort only.
 Our results indicate important differences in predic-
tors of SRH at follow-up in the early cohort compared to 
the late cohort after KT. For the early cohort after KT, a 
change in GFR over time and age are predictors associ-
ated with SRH at follow-up. We have previously reported 
similar results in a smaller sample  [12] . However, in the 
late cohort after KT, in addition to the change in GFR 
over time, the change in transplantation-associated psy-
chological distress over time and the number of late acute 
rejection episodes during the observation period contrib-
uted significantly to the explanation of the variance in 
SRH at follow-up.
 Late acute rejection episodes during the observation 
period seem to have a significant relationship to SRH at 
a late period after KT. So far, late acute rejection episodes 
cause lower GFR and poor SRH. Moreover, a decreased 
GFR predicts poor SRH, and not only when it occurs
during late acute rejection episodes. Djamali et al. [24] 
showed that decreased graft function after late acute re-
jection is associated with poor patient and allograft sur-
vival, which might be connected to poor SRH as well. 
Individual perceptions in disease-specific distress of 
transplantation also give the impression of having a sig-
nificant relationship to SRH at a late period after KT. 
Similar to our findings, Drent et al. [25] divided their 
group of transplanted patients into short- and long-term 
cohorts and showed differences between these groups: 
the long-term cohort reported more individual negative 
experiences than the short-term cohort did.
 Strengths and Limitations 
 The strength of this study is its longitudinal design, 
which enabled us to explore changes in factors associated 
with SRH as well as the associations between these chang-
es and SRH at follow-up in the early and the late cohorts 
stratified according to time after KT. Missing data is a 
limitation of this study; however, there were no differ-
ences in age and gender between respondents and nonre-
spondents. On the other hand, all consecutive patients 
originating from one major transplant center in Slovakia 
over a number of years were asked to participate in the 
study to prevent selection bias.
 Recommendations and Implications 
 Results must be verified in a larger sample to allow for 
generalization. In addition, we only studied patients from 
baseline to 3 and 12 months after transplantation; there-
fore, prolonging the study period is necessary. Thus, in a 
future study, pretransplantation SRH is needed to further 
study its role in influencing post-transplantation SRH at 
follow-up. We could then verify whether SRH after KT 
remains dependent on the factors found in the cohorts 
before transplantation, or whether in a longer period af-
Table 2. T he regression models of significant predictors of SRH at 




Model 1 in the early cohort (n = 89); adjusted R2 0.662
Constant 19.476; 52.544
SRH at baseline 0.644*** 0.484; 0.744
Change in GFR over time 0.569*** 48.572; 77.037
Age –0.160** –0.553; –0.050
Model 2 in the late cohort (n = 39); adjusted R2 0.604
Constant 11.363; 42.099
SRH at baseline 0.600*** 0.326; 0.859
Change in GFR over time 0.555*** 19.110; 57.104
Change in transplantation-associated
psychological distress over time –0.338** –14.810; –2.360
Number of late acute rejection episodes –0.306* –33.698; –2.975
* p < 0.05; ** p < 0.01; *** p < 0.001.
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ter KT other variables become important. Furthermore, 
the pathways between psychological, physical and medi-
cal determinants associated with SRH should be studied.
 In conclusion, improvement in graft function over 
time predicted better SRH at each period of follow-up. 
Decreased transplantation-associated psychological dis-
tress did not seem to be important in the first year after 
KT, instead only beyond 1 year after KT. Moreover, fewer 
late acute rejection episodes seemed to predict better SRH 
at a late follow-up period. Despite these observations, 
higher SRH was associated with better clinical outcomes.
 Acknowledgements 
 This work was supported by the Slovak Research and Develop-
ment Agency under contract No. APVV-20-038305 (80%) and 
partially supported by the Agency of the Slovak Ministry of Edu-
cation for the Structural Funds of the EU under project No. 
ITMS:26220120058 (20%).
 Disclosure Statement 
 The authors have no conflicts of interest.
 
 References 
 1 Benjamins MR, Hummer RA, Eberstein IW, 
Nam CB: Self-reported health and adult 
mortality risk: an analysis of cause-specific 
mortality. Soc Sci Med 2004; 59: 1297–1306. 
 2 Benyamini Y, Idler EL, Leventhal H, Leven-
thal EA: Positive affect and function as influ-
ences on self-assessments of health: expand-
ing our view beyond illness and disability. J 
Gerontol B Psychol Sci Soc Sci 2000; 55: 107–
116. 
 3 Thong MSY, Kaptein AA, Benyamini Y, 
Krediet RT, Boeschoten EW, Dekker FW: As-
sociation between a self-rated health ques-
tion and mortality in young and old dialysis 
patients: a cohort study. Am J Kidney Dis 
2008; 52: 111–117. 
 4 Spiegel BMR, Melmed G, Robbins S, Esrail-
ian E: Biomarkers and health-related quality 
of life in end-stage renal disease: a system-
atic review. Clin J Am Soc Nephrol 2008; 3: 
 1759–1768. 
 5 Avitzur Y, De Luca E, Cantos M, Jimenez-
Rivera C, Jones N, Fecteau A, Grant D, Lee 
Ng V: Health status ten years after pediatric 
liver transplantation – looking beyond the 
graft. Transplantation 2004; 78: 566–573. 
 6 DeSalvo KB, Bloser N, Reynolds K, He J, 
Muntner P: Mortality prediction with a single 
general self-rated health question. A meta-
analysis. J Gen Intern Med 2006; 21: 267–275. 
 7 Rebollo P, Ortega F, Baltar JM, Diaz-Corte C, 
Navascues RA, Naves M, Urena A, Badia X, 
Alvarez-Ude F, Alvarez-Grande J: Health-
related quality of life (HRQOL) in end stage 
renal disease (ESRD) patients over 65 years. 
Geriatr Nephrol Urol 1998; 8: 85–94. 
 8 Fujisawa M, Ichikawa Y, Yoshiya K, Isotani S, 
Higuchi A, Nagano S, Arakawa S, Hamami 
G, Matsumoto O, Kamidono S: Assessment 
of health-related quality of life in renal trans-
plant and hemodialysis patients using the SF-
36 health survey. Urology 2000; 56: 201–206. 
 9 Saracino A, Gollo I, Di Noia I, Caldone MG, 
Santarsia G, Procida C, Latorraca A, Gaudi-
ano V: Loss of renal function is associated 
with deterioration of health-related quality 
of life in kidney transplant patients. Trans-
plant Proc 2008; 40: 3460–3465. 
 10 Hathaway D, Winsett R, Prendergast M, 
Subaiya I: The first report from the patient 
outcomes registry for transplant effects on 
life (PORTEL): differences in side-effects 
and quality of life by organ type, time since 
transplant and immunosuppressive regi-
mens. Clin Transplant 2003; 17: 183–194. 
 11 Srinivas TR, Meier-Kriesche HU: Minimiz-
ing immunosuppression, an alternative ap-
proach to reducing side effects: objectives 
and interim result. Clin J Am Soc Nephrol 
2008; 3:S101–S116. 
 12 Majernikova M, Rosenberger J, Prihodova L, 
Nagyova I, Roland R, van Dijk JP, Groothoff 
JW: Self-rated health after kidney transplan-
tation and the change in graft function. Dial 
Transplant 2010; 39: 440–444. 
 13 Wolfe RA, Ashby VB, Milford EL, Ojo AO, 
Ettenger RE, Agodoa LY, Held PJ, Port FK: 
Comparison of mortality in all patients on 
dialysis, patients on dialysis awaiting trans-
plantation, and recipients of a first cadaveric 
transplant. N Engl J Med 1999; 341: 1725–
1730. 
 14 Laupacis A, Keown P, Pus N, Krueger H, Fer-
guson B, Wong C, Muirhead N: A study of 
the quality of life and cost-utility of renal 
transplantation. Kidney Int 1996; 50: 235–
242. 
 15 Ware JE Jr, Sherbourne CD: The MOS 36-
item Short-Form Health Survey (SF-36). I. 
Conceptual framework and item selection. 
Med Care 1992; 30: 473–483. 
 16 Wight JP, Edwards L, Brazier J, Walters S, 
Payne JN, Brown CB: The SF36 as an out-
come measure of services for end stage renal 
failure. Qual Health Care 1998; 7: 209–221. 
 17 Gomez-Besteiro MI, Santiago-Perez MI, 
Alonso-Hernandez A, Valdes-Canedo F, Re-
bollo-Alvarez P: Validity and reliability of 
the SF-36 questionnaire in patients on the 
waiting list for a kidney transplant and 
transplant patients. Am J Nephrol 2004; 24: 
 346–351. 
 18 Franke GH, Reimer J, Philipp T, Heemann U: 
Aspects of quality of life through end-stage 
renal disease. Qual Life Res 2003; 12: 103–115. 
 19 Franke GH, Reimer J, Kohnle M, Luetkes P, 
Maehner N, Heemann U: Quality of life in 
end-stage renal disease patients after suc-
cessful kidney transplantation: development 
of the ESRD Symptom Checklist – Trans-
plantation Module. Nephron 1999; 83: 31–39. 
 20 Cockcroft DW, Gault MH: Prediction of cre-
atinine clearance from serum creatinine. 
Nephron 1976; 16: 31–41. 
 21 Sis B, Mengel M, Haas M, Colvin RB, Hal-
loran PF, Racusen LC, Solez K, Baldwin III 
WM, Bracamonte ER, Broecker V, Cosio F, 
Demetris AJ, Drachenberg C, Einecke G, 
Gloor J, Glotz D, Kraus E, Legendre C, Liapis 
H, Mannon RB, Nankivell BJ, Nickeleit V, 
Papadimitriou JC, Randhawa P, Regele H, 
Renaudin K, Rodriguez ER, Seron D, Seshan 
S, Suthanthiran M, Wasowska BA, Zachary 
A, Zeevi A: Banff ‘09 Meeting Report: anti-
body mediated graft deterioration and im-
plementation of Banff working groups. Am J 
Transplant 2010; 10: 464–471. 
 22 Sijpkens YWJ, Doxiadis IIN, Mallat MJK, de 
Fijter JW, Bruijn JA, Claas FHJ, Paul LC: Ear-
ly versus late acute rejection episodes in renal 
transplantation. Transplantation 2003;  75: 
 204–208. 
 23 Joseph JT, Kingsmore DB, Junor BJ, Briggs 
JD, Mun Woo Y, Jaques BC, Hamilton DN, 
Jardine AG, Jindal RM: The impact of late 
acute rejection after cadaveric kidney trans-
plantation. Clin Transplant 2001; 15: 221–227. 
 24 Djamali A, Samaniego M, Torrealba J, Pirsch 
J, Muth BL: Increase in proteinuria  1 200 
mg/g after late rejection is associated with 
poor graft survival. Nephrol Dial Transplant 
2010; 25: 1300–1306. 
 25 Drent G, Moon P, De Geest S, Kleibeuker JH, 
Haagsma EB: Symptom experience associ-
ated with immunosuppressive drugs after 
liver transplantation in adults: possible rela-
tionship with medication non-compliance? 
Clin Transplant 2008; 22: 700–709. 
 
